Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 20 FEBRUARY 2025

Is It Time To Go Global? Cannabis Continues To Grow Internationally

MGO CPA LLP
Explore more from MGO CPA LLP

The international cannabis market is heating up, and U.S. companies are taking notice. With legalization gaining traction worldwide and demand surging for high-quality products...

GlobalCannabis & Hemp
Scott Hammon
Scott Hammon
Author LinkedIn connections

Key Takeaways:

  • Some U.S. cannabis companies are expanding internationally to break into new markets and capitalize on global legalization trends.
  • Strategic moves by brands like Curaleaf, Tilray, and Khalifa Kush highlight the opportunities — and challenges — of entering foreign markets.
  • Success in global expansion requires navigating complex regulations, financial logistics, and cultural differences to build a competitive international presence.

—

The international cannabis market is heating up, and U.S. companies are taking notice. With legalization gaining traction worldwide and demand surging for high-quality products, many cannabis brands are stepping beyond domestic borders to tap into new markets.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

The Intoxicating Hemp Products Ban Was Delayed A Month. Now What?

The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests from cannabis sellers, alcohol producers, and state regulators creating policy gridlock, the future of intoxicating hemp products remains uncertain as midterm elections approach.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

"Marijuana" Rescheduling Delayed, Again. What It Could Mean, And What Comes Next

The DEA's marijuana rescheduling hearing has been unexpectedly stayed following a motion to admit a new GAO report examining agency scheduling procedures. With the proceeding on hold and the medical marijuana Schedule III order facing legal challenges in the D.C. Circuit, the cannabis industry's path to federal tax relief through rescheduling has become increasingly uncertain.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

IRC Section 280E And Cannabis Tax Planning: Recent Developments And Practical Considerations

The landscape surrounding Section 280E of the Internal Revenue Code continues to evolve with President Trump's Executive Order on medical marijuana rescheduling, advancing litigation in New Mexico Top Organics v. Commissioner, and shifting regulatory signals. Cannabis taxpayers face critical decisions about taking "non-280E" positions on their tax returns while the IRS maintains its enforcement stance and the U.S. Tax Court case addressing common arguments remains pending.
United StatesCannabis & Hemp
Foley Hoag LLP
Foley Hoag LLP